Biome Australia rises on patent application for new probiotic strain
** Shares of Biome Australia BIO.AX rise as much as 1.5% to A$0.33, on track to log their best session since April 20 ** Biotherapeutics maker files patent application for its proprietary next-generation probiotic strain ** Marks co's entry into intellectual property development and innovation-driven growth, BIO says ** YTD, stock down 22% (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com; ))
Recent news on Biome Australia
See all newsBrief: Biome Australia To Launch In China
Brief: Biome Australia Posts FY26 Sales Revenue Rises 30% To A$23.9 Million
Biome Australia hits two-month high on upbeat full-year sales revenue
Brief: Biome Australia Logs FY Revenue of AUD 23.9 Million
Biome Australia soars on signing Australian manufacturing deal